Scott Gettinger

Summary

Affiliation: Yale University
Country: USA

Publications

  1. doi request reprint Targeted therapy in advanced non-small-cell lung cancer
    Scott Gettinger
    Section of Medical Oncology, Department of Internal Medicine, Yale Cancer Center, Yale University School of Medicine, New Haven, CT 06520, USA
    Semin Respir Crit Care Med 29:291-301. 2008
  2. doi request reprint A decade of advances in treatment for advanced non-small cell lung cancer
    Scott Gettinger
    Division of Medical Oncology, Yale University School of Medicine, 333 Cedar Street, FMP 127, New Haven, CT 06520, USA
    Clin Chest Med 32:839-51. 2011
  3. pmc High expression of BCL-2 predicts favorable outcome in non-small cell lung cancer patients with non squamous histology
    Valsamo K Anagnostou
    Department of Pathology, Yale University School of Medicine, New Haven, CT, USA
    BMC Cancer 10:186. 2010
  4. pmc High SOX2 levels predict better outcome in non-small cell lung carcinomas
    Vamsidhar Velcheti
    Department of Medical Oncology, Yale University School of Medicine, New Haven, Connecticut, USA
    PLoS ONE 8:e61427. 2013
  5. doi request reprint High expression of mammalian target of rapamycin is associated with better outcome for patients with early stage lung adenocarcinoma
    Valsamo K Anagnostou
    Department of Pathology, Section of Medical Oncology, Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut 06520 8023, USA
    Clin Cancer Res 15:4157-64. 2009
  6. ncbi request reprint Treatment of lung cancer in older patients
    Lynn T Tanoue
    Section of Pulmonary and Critical Care Medicine, Yale School of Medicine, 333 Cedar St, New Haven, CT 06520, USA
    Clin Chest Med 28:735-49, vi. 2007
  7. ncbi request reprint Complications of therapy in cancer patients: Case 2. Scrotal ulceration during all-trans-retinoic acid therapy for acute promyelocytic leukemia
    Scott Gettinger
    Beth Israel Medical Center, New York, NY, USA
    J Clin Oncol 22:4648-9. 2004

Collaborators

Detail Information

Publications7

  1. doi request reprint Targeted therapy in advanced non-small-cell lung cancer
    Scott Gettinger
    Section of Medical Oncology, Department of Internal Medicine, Yale Cancer Center, Yale University School of Medicine, New Haven, CT 06520, USA
    Semin Respir Crit Care Med 29:291-301. 2008
    ..Research efforts are currently focusing on tailoring such therapies according to predictive clinical and molecular markers...
  2. doi request reprint A decade of advances in treatment for advanced non-small cell lung cancer
    Scott Gettinger
    Division of Medical Oncology, Yale University School of Medicine, 333 Cedar Street, FMP 127, New Haven, CT 06520, USA
    Clin Chest Med 32:839-51. 2011
    ..Several other biomarkers are the focus of ongoing prospective randomized clinical trials customizing both traditional chemotherapy and newer molecularly targeted agents...
  3. pmc High expression of BCL-2 predicts favorable outcome in non-small cell lung cancer patients with non squamous histology
    Valsamo K Anagnostou
    Department of Pathology, Yale University School of Medicine, New Haven, CT, USA
    BMC Cancer 10:186. 2010
    ..Bcl-2 has been investigated as a prognostic factor in non small cell lung cancer (NSCLC) patients with conflicting results...
  4. pmc High SOX2 levels predict better outcome in non-small cell lung carcinomas
    Vamsidhar Velcheti
    Department of Medical Oncology, Yale University School of Medicine, New Haven, Connecticut, USA
    PLoS ONE 8:e61427. 2013
    ..The aim of the present study was to evaluate SOX2 expression in NSCLC and determine the relationship with clinico-pathological variables and outcome...
  5. doi request reprint High expression of mammalian target of rapamycin is associated with better outcome for patients with early stage lung adenocarcinoma
    Valsamo K Anagnostou
    Department of Pathology, Section of Medical Oncology, Yale Cancer Center, Yale University School of Medicine, New Haven, Connecticut 06520 8023, USA
    Clin Cancer Res 15:4157-64. 2009
    ..Here, we quantitatively assessed mTOR protein expression in two large data sets to investigate the impact of mTOR expression on patient survival...
  6. ncbi request reprint Treatment of lung cancer in older patients
    Lynn T Tanoue
    Section of Pulmonary and Critical Care Medicine, Yale School of Medicine, 333 Cedar St, New Haven, CT 06520, USA
    Clin Chest Med 28:735-49, vi. 2007
    ....
  7. ncbi request reprint Complications of therapy in cancer patients: Case 2. Scrotal ulceration during all-trans-retinoic acid therapy for acute promyelocytic leukemia
    Scott Gettinger
    Beth Israel Medical Center, New York, NY, USA
    J Clin Oncol 22:4648-9. 2004